Vasoactive drugs inhibit oxygen radical production of neutrophils

Immunopharmacology and Immunotoxicology

Volumn 19, Issue 2, 1997, Pages 239-263

  Weiss, M ^a   Schneider, E M ^b   Liebert, S ^b   Mettler, S ^b   Lemoine, H ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMRINONE; DOBUTAMINE; DOPAMINE; ENOXIMONE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; NIFEDIPINE; NORADRENALIN; OXYGEN RADICAL; PROSTACYCLIN; VASOACTIVE AGENT; ZYMOSAN;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CHEMOTAXIS; HUMAN; HUMAN CELL; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030997083     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.3109/08923979709007661     Document Type: Article

References (45)

1. Kress, H. G., Eberlein, T., Hörber, B. and Weis, K. H., Suppression of Neutrophil Migration and Chemiluminescence is Due to The Sulphur Atom in The Thiobarbiturate Molecule, Acta Anaesthesiol. Scand., 33:122, 1989.
2. Weiss, M., Mirow, N., Birkhahn, A., Schneider, M. and Wernet, P., Benzodiazepines and Their Solvents Influence Neutrophil Granulocyte Function, Br. J. Anaesth., 70:317, 1993.
3. Eberhardt, K. E. W., Thimm, B. M., Spring, A. and Maskos, W. R., Dose-Dependent Rate of Nosocomial Pulmonary Infection in Mechanically Ventilated Patients With Brain Oedema Receiving Barbiturates: A Prospective Case Study, Infection, 20:16, 1992.
4. Babior, B. M., Oxygen-dependent Microbial Killing by Phagocytes, N. Engl. J. Med., 298:721, 1978.
5. 4, Formylpeptide and Phorbolester, Scand. J. Clin. Lab. Invest., 49:317, 1989.
6. Bruchelt, G. and Schmidt, K. H., Comparative Studies on The Oxidative Processes During Phagocytosis Measured by Luminol-Dependent Chemiluminescence, J. Clin. Chem. Clin. Biochem., 22:1, 1984.
7. Vespasiano, M. C., Lewandoski, J. R. and Zimmerman, J. J., Longitudinal Analysis of Neutrophil Superoxide Anion Generation in Patients With Septic Shock, Crit. Care Med., 21:666, 1993.
8. 2+-dependent Mechanism Which Is Independent of Transmembrane Activation of Adenylate Cyclase, J. Biol. Chem., 260:6769, 1985.
9. Simchowitz, L., Fischbein, L. C., Spilberg, I. and Atkinson, J. P., Induction of a Transient Elevation in Intracellular Levels of Adenosine-3′,5′-Cyclic Monophosphate by Chemotactic Factors: An Early Event in Human Neutrophil Activation, J. Immunol., 124:1482, 1980.
10. Boyum, A., Isolation of Mononuclear Cells and Granulocytes From Human Blood, Scand. J. Clin. Lab. Invest., 21(Suppl. 97):77, 1968.
11. Ferrante, A. and Thong, Y. H., Optimal Conditions For Simultaneous Purification of Mononuclear and Polymorphonuclear Leukocytes from Human Peripheral Blood by The Hypaque-Ficoll Method, J. Immunol. Methods, 36:109, 1980.
12. Ensinger, H., Lindner, K. H. K., Dirks, B., Kilian, J. and Grünert, A., Adrenaline: Relationship Between Infusion Rate, Plasma Concentration, Metabolic and Hemodynamic Effects in Volunteers, Eur. J. Anaesthesiol., 9:435, 1992.
13. Lande, K., Gjesdal, K., Fønstelien, E., Kjeldsen, S. E. and Eide, I., Effects of Adrenaline on Platelet Number, Volume and Release Reaction, Thromb. Haemost., 54:450, 1985.
14. 2, Anesth. Analg., 61:366, 1982.
15. Ljunhgall, S., Åkerström, G., Benson, L., Hetta, J., Rudberg, C. and Wide, L., Effects of Epinephrine and Norepinephrine on Serum Parathyroid Hormone and Calcium in Normal Subjects, Exp. Clin. Endocrinol., 84:313, 1984.
16. Kates, R. E. and Leier, C.V., Dobutamine Pharmacokinetics in Severe Heart Failure, Clin. Pharmacol. Ther., 24:537, 1978.
17. Lande, K., Os, I., Kjeldsen, S. E., Westheim, A., Hjerman. I., Eide, I. and Gjesdal, K., Effect of Dopamine and Dopamine-Antagonist Infusion on Blood Platelet Count, Size and Release Reaction in Hypertensive and Normotensive Subjects, Scand. J. Clin. Lab. Invest., 49:307, 1989.
18. Padbury, J. F., Youtaro, A., Baylen, B. G., Ludlow, J. K., Polk, D. H., Goldblatt, E. and Pescetti, J., Dopamine Pharmacokinetics in Critically III Newborn Infants, Pediatric Pharmacology and Therapeutics, 110:293, 1986.
19. Edelson, J., LeJemtel, T. H., Alousi, A. A., Biddlecome, C. E., Maskin, C. S. and Sonnenblick, E. H., Relationship Between Amrinone Plasma Concentration and Cardiac Index, Clin. Pharmacol. Ther., 29:723, 1981.
20. Goenen, M., Pedemonte, O., Baele, P. and Col, J., Amrinone in The Management of Low Cardiac Output After Open Heart Surgery, Am. J. Cardiol., 56:33B, 1985.
21. Kullenberg, M. P., Freeman, G. B., Biddlecome, C., Alousi, A. A. and Edelson, J., Der Metabolismus von Amrinon, Clin. Pharmacol. Ther., 29:394, 1981.
22. Boldt, J., Kling, D., Dieterich, H. A., Marck, P. and Hempelmann, G., The New Phosphodiesterase Inhibitor Enoximone in Patients Following Cardiac Surgery - Pharmacokinetics and Influence on Parameters of Coagulation, Intensive Care Med., 16:54, 1990.
23. Hudson, J. C., Wurm, W. H., O'Donnel, T. F., Kane, F. R., Mackey, W. C., Su, J. F. and Watkins, W. D., Ibuprofen Pretreatment Inhibits Prostacyclin Release During Abdominal Exploration in Aortic Surgery, Anesthesiology, 72:443, 1990.
24. 2 in Type 1 (Insulin-dependent) Diabetic Patients During Exercise, Diabetologia, 30:460, 1987.
25. v. Bortel, L., Böhm, R., Mooij, J., Schiffers, P. and Rahn, K. H., Total and Free Steady-state Plasma Levels and Pharmacokinetics of Nifedipine in Patients With Terminal Renal Failure, Eur. J. Clin. Pharamcol., 37:185, 1989.
26. Kleinbloesem, C. H., van Brummelen, P., Danhof, M., Faber, H., Urquhart, J. and Breimer, D. D., Rate of Increase in The Plasma Concentration of Nifedipine As A Major Determinant of Its Hemodynamic Effects in Humans, Clin. Pharmacol. Ther., 41:26, 1986.
27. Kuwaiima, I. and Kuramoto, K., Pharmacokinetics and Pharmacodynamics of Antihypertensive Drugs in The Elderly, Nippon Ronen Igakkai Zasshi, 26:131, 1989.
28. Schulz, M., Wischhusen, F. and Schmoldt, A., Therapeutische und Toxische Plasmakonzentrationen sowie Eliminationshalbwertszeiten Gebräuchlicher Arzneistoffe, Anasthesiol. Intensivmed. Notfallmed. Schmerzther., 26:37, 1991.
29. Sorkin, E. M., Clissold, S. P. and Brogden, R. N., Nifedipine. A Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy, in Ischaemic Heart Disease, Hypertension and Related Cardiovascular Disorders, Drugs, 30:182, 1985.
30. Sorkin, E. M., Brogden, R. N. and Romankiewicz, J. A., Intravenous Glyceryl Trinitrate (Nitroglycerin): A Review of Its Pharmacological Properties and Therapeutic Efficacy, Drugs, 27:45, 1984.
31. Abruzzo, G. K., Fromtling, R. A., Turnbull, T. A. and Giltinan, D. M., Effects of Bifonazole, Fluconazole, Itraconazole and Terbinafine on The Chemiluminescence Response of Immune Cells, J. Antimicrob. Chemother., 20:61, 1987.
32. Marasco, W. A., Phan, S. H., Krutzsch, H., Showell, H. J., Feltner, D. E., Nairn, R., Becker, E. L. and Ward, P. A., Purification and Identification of Formyl-Methionyl-Leucyl-Phenylalanine as The Major Peptide Neutrophil Chemotactic Factor Produced by Escherichia Coli, J. Biol. Chem., 259:5430, 1984.
33. Gerard, C. and Gerard, N. P., The Pro-inflammatory Seven-Transmembrane Segment Receptors of The Leukocyte, Curr. Opin. Immunol., 6:140, 1994.
34. 23187 Stimulated Respiratory Burst of Human PMNLs, Biochem. Int., 17:419, 1988.
35. 2 in Intact Human Neutrophils But Not in The Cell-Free System, Biochem. Biophys. Res. Commun., 138:1099, 1986.
36. Nielson, C. P., Bayer, C., Hodson, S. and Hadjokas, N., Regulation of The Respiratory Burst by Cyclic 3′, 5′-AMP, An Association with Inhibition of Arachidonic Acid Release, J. Immunol., 149:4036, 1992.
37. Seifert, R. and Schultz, G., in Reviews of Physiology Biochemistry and Pharmacology 117 The Superoxide-forming NADPH Oxidase of Phagocytes: An Enzyme System Regulated by Multiple Mechanisms, edited by M. P. Blaustein, pp. 160-166, Springer, Berlin Heidelberg New York, 1991.
38. Coutinho, G. C., Durieu-Trautmann, O., Strosberg, A. D. and Couraud, P. O., Catecholamines Stimulate The IFN-γ-Induced Class II MHC Expression on Bovine Brain Capillary Endothelial Cells, J. Immunol., 147:2525, 1991.
39. Bazzoni, G., Dejana, E. and Del Maschio, A., Adrenergic Modulation of Human Polymorphonuclear Leucocyte Activation. Potentiating Effect of Adenosine, Blood, 77:2042, 1991.
40. 3H]-Dihydroalprenolol to Human Polymorphonuclear Cell Particulates, J. Lab. Clin. Med., 92:613, 1978.
41. Fraser, J., Nadeau, J., Robertson, D. and Wood, A. J. J., Regulation of Human Leukocyte Beta Receptors by Endogenous Catecholamines. Relationship of The Cardiac Sensitivity to Isoproterenol, J. Clin. Invest., 67:1777, 1981.
42. Hatch, G. E., Nichols, W. K., Hill, H. R., Cyclic Nucleotide Changes in Human Neutrophils Induced by Chemoattractants and Chemotactic Modulators, J. Immunol., 119:450, 1977.
43. 4 Induced Steady State Calcium Rise and Superoxide Anion Generation in Guinea Pig Eosinophils Are Not Related Events, Biochem. Biophys. Res. Commun., 187:670, 1992.
44. Simchowitz, L. and Spilberg, I., Generation of Superoxide Radicals by Human Peripheral Neutrophils Activated by Chemotactic Factor. Evidence For The Role of Calcium, J. Lab. Clin. Med., 93:583, 1979.
45. Rekker, R. F. and Mannhold, R. Calculation of Drug Lipophilicity. The Hydrophobic Fragmental Constant Approach, VCH Verlagsgesellschaft mbH, Weinheim, New York Basel Cambridge 1992.